New evidence-based PCF Prostate Cancer Screening Guidelines for Black Men in the U.S. recommend that Black men consider PSA screening between ages 40-45, and screen annually depending on PSA levels and health status. 🧵⬇️

Concluding #EAU24 in beautiful Paris with immense gratitude to European Association of Urology (EAU), European Association of Urology (EAU)ESU & European Urology for a fantastic conference filled with new knowledge and delightful experiences to better patient care. Arnulf Stenzl Renu Eapen Declan Murphy Shankar Siva Roderick van den Bergh Bárbara Melão

Excellent discussion on the role of pelvic lymph node dissection at the time of radical prostatectomy. Prof. Karim Touijer UrologyMSK presents new RCT data demonstrating therapeutic benefit of extended PLND. Freddie Hamdy discusses which patients should have PLND. #EAU24

🚨✨NEW study just out in JAMA ✨🚨 Prof. Anssi Auvinen presents Pro-Screen trial: PSA+4K panel+MRI shifting harms to benefits. #EAU23

#EAU24 Anssi Auvinen Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI jamanetwork.com/journals/jama/…

New data from PROBASE trial presented by Prof. Albers at #EAU24 : Men at 45 with a baseline PSA < 1.5 have a very low risk of developing clinically significant PCa in the next 5 years. Just published in European Urology

✨NEW trial data✨ Prostate MRI without contrast? Plenary room overflowing with #EAU24 delegates when Prof. Veeru Kasi presents multi-institutional PRIME study. Data supports biparametric MRI as the new standard of care in PCa early detection—when quality of MRI is high.

Really interesting new data on PCa screening #EAU24 Re-Imagine trial Caroline Moore shows many PCa in men < 3 ng/mL but Göteborg-2 trial shows possible overdiagnosis in 1.8-3 ng/mL European Urology. PRAISE-U and Organized Prostate Testing programs will provide more data. Praise_U

🚨 Hot off the press 🚨 at #EAU24 Profs. Martin and Freddie Hamdy presenting CAP trial. A one-time PSA test reduces PCa mortality at 15 years—but may miss some lethal cases. Regular risk-stratified screening is key.

Excellent plenary by Prof. Monique Roobol on risk-stratified prostate cancer screening #EAU24

Our great Viewpoint about being a non-native English speaker in science and medicine was so well-received, and also inspired a great journal cover this month! Take a look if you missed it rdcu.be/dAz4m

Insightful session on the role of molecular tests and MRI for screening men and/or localized dz at #IPCU2024 by Alan H Bryce Matt Cooperberg Brian Helfand MD, PhD Sigrid Carlsson

A fond farewell from our awesome 1st years fellows to Brazilian urologist Bárbara Melão who spent part of her PhD with Sigrid Carlsson and Karim Touijer ! Was great getting to know you Barbara!